Trailing-twelve-month (TTM) revenue is $18.30 Million with a year-over-year growth of +47.63%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $5,013,872 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-13 |
| Q4 FY2025Period ended 2025-12-31 | $4,742,903 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-26 |
| Q1 FY2026Period ended 2026-03-31 | $3,312,800 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13 |
| Q2 FY2026Period ended 2026-06-30 | $5,229,660 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-11 |
| TTM revenue | $18,299,235 |
Current P/S: $5,889,912 market capitalization ÷ $18,299,235 TTM revenue = 0.32x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $5.23M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:53:36.510Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD |
|---|---|
| Other | $19,290 |
$18.30M
$18.30 Million
+47.63%
vs. $12.40M a year ago (TTM)
+111.47%
5 Year compound annual growth rate
1 Year
+47.63%
3 Year
+298.36%
5 Year
+111.47%
10 Year
+43.32%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $16.10M | +$7.62M | +89.78% |
| 2024 | $8.48M | +$6.95M | +454.67% |
| 2023 | $1.53M | +$1.41M | +1212.97% |
| 2022 | $116,502 | ($187,248) | (61.65%) |
| 2021 | $303,750 | ($42,394) | (12.25%) |
| 2020 |
TTM Growth
+47.63%
3-Year CAGR
+298.36%
5-Year CAGR
+111.47%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T20:53:36.510Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $346,144 |
| ($1.58M) |
| (82.03%) |
| 2019 | $1.93M | +$1.44M | +300.07% |
| 2018 | $481,521 | +$72,820 | +17.82% |
| 2017 | $408,701 | +$47,578 | +13.18% |
| 2016 | $361,123 | ($290,544) | (44.58%) |
